Based on the analysis, tirzepatide is expected to receive FDA approval for obesity by the end of 2023, and analysts predict that its sales could surpass those of Wegovy, provided that Lilly can continue to build on the potentially superior efficacy of tirzepatide
Everyones journey is different, and individual results vary based on lifestyle, consistency, dose, and personal response
Weeks 5-8 (5mg): adapt to stronger suppression The first dose increase often surprises people with its impact on appetite
It reduces motivation to exercise
Yes, preventive strategies include allowing the pen to reach room temperature before injection, systematically rotating injection sites each week, ensuring proper 90-degree needle insertion technique, and avoiding injection into bruised or damaged skin
Women should maintain open communication with their healthcare providers about reproductive health changes throughout treatment